Evidence map›Paper›PMID 39777564›Full record

ArticleTransgenic research2025

Do confined field trials add value for the environment risk assessment of genetically modified Brassica napus L. in Japan?

Kei Takamoto, Kaori Inazu, Shuichi Nakai, Koichi Inoue, Mai Tsuda

Abstract read
In one paragraph

Article in Transgenic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kei TakamotoBayer CropScience K.K., Marunouchi Kitaguchi Bldg, 1-6-5, Marunouchi, Chiyoda-ku, Tokyo, 100-8262, Japan.
Kaori InazuBASF Japan Ltd., 3-4-4 Nihonbashi Muromachi, Chuo-ku, Tokyo, 103-0022, Japan.
Shuichi NakaiBayer CropScience K.K., Marunouchi Kitaguchi Bldg, 1-6-5, Marunouchi, Chiyoda-ku, Tokyo, 100-8262, Japan.
Koichi InoueBASF Japan Ltd., 3-4-4 Nihonbashi Muromachi, Chuo-ku, Tokyo, 103-0022, Japan.
Mai TsudaFaculty of Food and Nutritional Sciences, Toyo University, 48-1 Oka, Asaka-shi, Saitama, 351-8510, Japan. tsuda061@toyo.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The environmental risk assessment (ERA) of genetically modified (GM) crops in Japan requires collecting data from a comparative study of a GM and non-GM control in an in-country confined field trial (CFT). This in-country CFT requirement is used to address concerns that differences in the local environmental conditions may lead to differences in growth and/or risks of GM crops. However, this requirement for in-country CFT has recently been exempted for certain GM maize and GM cotton traits, and instead CFT data from other countries are used to inform the ERA of these GM events. However, in-country CFTs continue to be required for GM B. napus. Our objective is to assess whether using B. napus as a host crop increases the potential for differences between GM B. napus and conventional B. napus that may have an impact on biodiversity occurring only under the Japanese environment. In this paper agronomic data was compiled from seven local CFTs of GM B. napus events to assess the potential for differences between GM and non-GM B. napus for three key areas; competitiveness, potential to produce harmful substances, and outcrossing. Considering these elements, the need for conducting CFTs locally for ERA of future GM B. napus traits is discussed. The assessment concluded that conducting CFT locally is not necessary for GM B. napus events if traits do not bring competitive advantage or produce harmful substances only under Japanese environment.

Indexed as

Brassica napusCrops, AgriculturalPlants, Genetically ModifiedAgricultureEnvironmentJapanRisk AssessmentConfined field trialsData transportabilityEnvironmental risk assessmentGenetically modified crops

Identifiers

PMID39777564
PMCPMC11706835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.